Kyushu University · Faculty of Medicine / Graduate School of Medical Sciences

Research keywordscancer peptide vaccines・RNF43 peptide therapy・cyclophosphamide adjuvants・TLR7 agonists・GM-CSF antitumor immunity・plasmacytoid dendritic cells・hybrid liposomes・tumor cell apoptosis

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors.2018 · PLoS One 13 ( 1 ) 1 - 21 2018年1月
• Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors.2016 · Clinical Immunology 166 ( 48 ) 48 - 58 2016年5月
• TLR7 ligand augments GM-CSF-initiated antitumor immunity through activation of plasmacytoid dendritic cells.2014 · Cancer Immunol Res. 2 ( 6 ) 568 - 580 2014年4月
• 固形腫瘍に対する新規免疫療法の開発―当科における第I相臨床試験の現状―2012 · 臨床血液 53 ( 5 ) 487 - 492 2012年6月

• 医療技術実用化総合促進事業2018 · 2018年4月 - 2019年3月

• Official profile